Sacral Neuromodulation and Pudendal Somatic Afferents
The Involvement of Pudendal Somatic Afferents in Sacral Neuromodulation Assessed by Somatosensory Evoked Potentials of the Pudendal Nerve
1 other identifier
observational
40
1 country
1
Brief Summary
Sacral neuromodulation is a well-excepted minimally invasive procedure for the treatment of overactive bladder and non-obstructive urinary retention.A tined lead with 4 stimulation electrodes is placed through the third or fourth sacral foramen and stimulates sacral roots in its vicinity. Since the sacral roots are mixed nerves, it is currently still unknown which nerve fibers are stimulated (autonomic vs somatic, afferent vs efferent) and what the mechanism of action is. This study examines the involvement of pudendal somatic afferents by measuring somatosensory evoked potentials elicited by stimulation of the pudendal nerve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2017
CompletedFirst Submitted
Initial submission to the registry
July 30, 2018
CompletedFirst Posted
Study publicly available on registry
August 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2022
CompletedOctober 15, 2019
October 1, 2019
5 years
July 30, 2018
October 13, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Latency change
Latency of somatosensory evoked potential are recorded before and after test procedure sacral neuromodulation expressed in milliseconds.
3 weeks
Study Arms (2)
Successes
Patients with reduction of symptoms \>50% during the test procedure for sacral neuromodulation.
Failures
Patients with reduction of symptoms \<50% during the test procedure for sacral neuromodulation.
Interventions
Stimulation of the pudendal nerve while recording at the sensory cortex.
Eligibility Criteria
Urological patients with overactive bladder or non-obstructive urinary retention.
You may qualify if:
- Overactive bladder
- Non-obstructive urinary retention
You may not qualify if:
- Neurogenic disorders (e.g. cerebrovascular accident, spinal cord injury,...)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD student
Study Record Dates
First Submitted
July 30, 2018
First Posted
August 3, 2018
Study Start
August 1, 2017
Primary Completion
July 31, 2022
Study Completion
July 31, 2022
Last Updated
October 15, 2019
Record last verified: 2019-10